There were several devices in the New Product Showcase at the Society of Interventional Radiology’s Annual Scientific Meeting in Los Angeles, USA. Among these was Medtronic’s OptiSphere resorbable embolization spheres, which the company introduced at the meeting.
OptiSphere resorbable spheres provide an alternative solution for treating hypervascular tumours, according to the company.
OptiSphere is made from purified porcine skin gelatin and the spherical shape provides smooth embolic delivery and even, predictable embolization. These resorbable microspheres begin to degrade starting at four weeks post-procedure with significant degradation noted at nine weeks, the company states. The product is offered in two volume options and five size ranges designed for reliable, targeted embolization of hypervascular tumours.
Included in a selection of the new products seen by Interventional News was Teleflex’s Octane thrombectomy system, which is intended for the removal of peripheral arterial and deep venous thrombosis. The system consists of a thrombectomy catheter and a hand pump for selective and controlled aspiration. The catheter assembly is a combination of two coaxial catheters with a 6F inner and 8F outer lumen that slide back and forth. This combination is designed to break up and remove thrombus plugging the catheter tip, the company states.
Bard, which is now part of BD, showcased the PowerFlow implantable apheresis IV port, which, the company states, is the only high-flow, power injectable port designed and indicated specifically for therapeutic apheresis.
Another product from the company was the UltraScore focused forced percutaneous transluminal angioplasty balloon. This is an over-the-wire scoring balloon that uses focused force technology to cause plaque fracture at low inflation pressures, even in calcified lesions. Compared to a standard angioplasty balloon, the UltraScore balloon provides 24 times more force when the wire contacts the lesions, material from the company states.
Argon Medical showcased BioPince Ultra, the latest innovation in biopsy technology. BioPince Ultra uses a triaxial core, cut and capture cannula system to harvest diagnostic quality, full core specimens while reducing the risk of crush artifact and tissue fragmentation.
Siemens Healthineers showcased nexaris Angio-CT to individualise treatment with seamless access to multiple imaging modalities in one interventional suite. The nexaris therapy suite provides synergised imaging for planning, guidance and results assessment during a single procedure, material from the company states.
BTG, which acquired Roxwood Medical in October 2017, showcased its range of anchoring catheters and microcatheter obtained from the acquisition. These offer options for physicians in the crossing of complex lesions and arterial blockages.